AMBEV S.A. current report, Q4 FY2022

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of December 2022. The report is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding treasury share positions rather than a financial performance report.

  • Treasury Shares (Common): 8,634,764
  • Treasury ADRs (Common): 0

Material Changes

There were no material changes to the company's securities or derivatives positions during the reporting period.

  • Transactions in November 2022: None. The registrant explicitly indicated that no securities and derivatives operations took place.
  • Balance Comparison: The initial balance of 8,634,764 common shares remained unchanged as the final balance.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting the absence of trading activity in treasury securities.

Investor Verification Checklist

  • Verify that the treasury share count of 8,634,764 remains accurate in subsequent filings.
  • Confirm that no derivative transactions occurred in the period following this report.
  • Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial metrics.